Pharmacogenetic Study of Mirtazapine Response in Depressed Patients.

Trial Profile

Pharmacogenetic Study of Mirtazapine Response in Depressed Patients.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2016

At a glance

  • Drugs Mirtazapine (Primary)
  • Indications Depression
  • Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 30 Dec 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017 as reported by ClinicalTrials.gov.
    • 02 Jul 2012 Planned End Date changed from 1 Mar 2012 to 1 Mar 2015 as reported by ClinicalTrials.gov.
    • 08 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top